Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of glioblastoma in the elderly.
Sahebjam S, McNamara M, Mason WP. Sahebjam S, et al. Clin Adv Hematol Oncol. 2012 Jun;10(6):379-86. Clin Adv Hematol Oncol. 2012. PMID: 22895239 Review.
Anaplastic oligodendroglioma: advances and treatment options.
McNamara MG, Sahebjam S, Mason WP. McNamara MG, et al. Among authors: sahebjam s. Curr Treat Options Neurol. 2013 Jun;15(3):289-301. doi: 10.1007/s11940-013-0218-9. Curr Treat Options Neurol. 2013. PMID: 23344797
Emerging biomarkers in glioblastoma.
McNamara MG, Sahebjam S, Mason WP. McNamara MG, et al. Among authors: sahebjam s. Cancers (Basel). 2013 Aug 22;5(3):1103-19. doi: 10.3390/cancers5031103. Cancers (Basel). 2013. PMID: 24202336 Free PMC article.
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF. Ellingson BM, et al. Among authors: sahebjam s. Neuro Oncol. 2017 Jan;19(1):89-98. doi: 10.1093/neuonc/now187. Epub 2016 Aug 31. Neuro Oncol. 2017. PMID: 27580889 Free PMC article. Clinical Trial.
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
McNamara MG, Jiang H, Lim-Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason WP. McNamara MG, et al. Among authors: sahebjam s. Can J Neurol Sci. 2017 May;44(3):288-294. doi: 10.1017/cjn.2016.420. Can J Neurol Sci. 2017. PMID: 28488951
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Lee EQ, Selig W, Meehan C, Bacha J, Barone A, Bloomquist E, Chang SM, de Groot JF, Galanis E, Hassan I, Kalidas C, Khasraw M, Kvedar JC, Lassman AB, Puduvalli V, Sahebjam S, Schwamm LH, Tamir S, Welch M, Yung WKA, Zadeh G, Arons D, Wen PY. Lee EQ, et al. Among authors: sahebjam s. Neuro Oncol. 2021 Aug 2;23(8):1252-1260. doi: 10.1093/neuonc/noab082. Neuro Oncol. 2021. PMID: 33822177 Free PMC article.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M. Reardon DA, et al. Among authors: sahebjam s. JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024. JAMA Oncol. 2020. PMID: 32437507 Free PMC article. Clinical Trial.
77 results